Cargando…
Galactose as Broad Ligand for Multiple Tumor Imaging and Therapy
Galactose residues could be specifically recognized by the asialoglycoprotein receptor (ASGPR) which is highly exhibited on liver tissues. However, ASGPR has not been widely investigated on different tumor cell lines except for hepatoma carcinoma cells, which motivates us to investigate the possibil...
Autores principales: | Ma, Yuxiang, Chen, Haiyan, Su, Shanyuhan, Wang, Tong, Zhang, Congying, Fida, Guissi, Cui, Sisi, Zhao, Juan, Gu, Yueqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466416/ https://www.ncbi.nlm.nih.gov/pubmed/26078797 http://dx.doi.org/10.7150/jca.11647 |
Ejemplares similares
-
The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapy
por: Li, Siwen, et al.
Publicado: (2014) -
Small Sized EGFR1 and HER2 Specific Bifunctional Antibody for Targeted Cancer Therapy
por: Ding, Li, et al.
Publicado: (2015) -
Multifunctional Gold Nanostar Conjugates for Tumor Imaging and Combined Photothermal and Chemo-therapy
por: Chen, Haiyan, et al.
Publicado: (2013) -
Pharmacophore Modeling and Virtual Screening for the Discovery of New type 4 cAMP Phosphodiesterase (PDE4) Inhibitors
por: Niu, Miaomiao, et al.
Publicado: (2013) -
Oxygen‐Depleted Calixarenes as Ligands for Molecular Models of Galactose Oxidase
por: Keck, Matthias, et al.
Publicado: (2019)